Robust Drug Pipeline Highlights Specialty Pharmacy Week in Review

Top stories of the week on Specialty Pharmacy Times from April 20 to April 24.

Specialty Drugs Dominate Late-Stage Pipeline

Record number of orphan drugs approved in 2014.

http://www.specialtypharmacytimes.com/news/Specialty-Drugs-Dominate-Late-Stage-Pipeline

Adherence is Paramount in Era of Rising Specialty Drug Costs

Catamaran chief medical officer discusses various trends that will impact specialty medications into the future.

http://www.specialtypharmacytimes.com/news/Adherence-is-Paramount-in-Era-of-Rising-Specialty-Drug-Costs

MS Drug Combination Repairs Damaged Brain Cells, Reverses Paralysis

Topical medications that treat skin conditions prompt stem cells in the brain to repair damage.

http://www.specialtypharmacytimes.com/news/MS-Drug-Combination-Repairs-Damaged-Brain-Cells-Reverses-Paralysis

Pfizer’s Lung Cancer Drug Receives Breakthrough Designation

Pfizer seeking to expand approved use of Xalkori to patients with ROS1-positive non-small cell lung cancer.

http://www.specialtypharmacytimes.com/news/Pfizers-Lung-Cancer-Drug-Receives-Breakthrough-Designation

Protein Inhibition Therapy Holds Promise for Treating Several Cancer Types

Regulating PD-L1 protein that helps cancer evade immune system suggests new therapeutic approach.

http://www.specialtypharmacytimes.com/news/Protein-Inhibition-Therapy-Holds-Promise-for-Treating-Several-Cancer-Types

Extending Dose of Multiple Sclerosis Drug Safe and Effective

Pushing treatment with natalizumab from 4 weeks up to 8 weeks shows promising results.

http://www.specialtypharmacytimes.com/news/Extending-Dose-of-Multiple-Sclerosis-Drug-Safe-and-Effective

Multiple Sclerosis Drug Effective Fighting HIV Viral Reservoir

Medication also used in treatment of Crohn’s disease effective at blocking pathways.

http://www.specialtypharmacytimes.com/news/Multiple-Sclerosis-Drug-Effective-Fighting-HIV-Viral-Reservoir

Prostate Cancer Drug Label Updated with Survival Data

Study showed a median overall survival of nearly 3 years with Zytiga plus prednisone.

http://www.specialtypharmacytimes.com/news/Prostate-Cancer-Drug-Label-Updated-with-Survival-Data

Racial Disparities in Cancer Death Rate Declining

Mortality gap in cancer deaths among African Americans and Caucasians may eventually disappear.

http://www.specialtypharmacytimes.com/news/Racial-Disparities-in-Cancer-Death-Rate-Declining

Otezla Shows Promise in Treatment of Rare Inflammatory Disease

Treatment found to improve several measures of disease activity and quality of life in patients with Behçet's disease.

http://www.specialtypharmacytimes.com/news/Otezla-Shows-Promise-in-Treatment-of-Rare-Inflammatory-Disease